# Phase I Trial of an Investigational Small Pox Medication

> **NCT00728689** · PHASE1 · COMPLETED · sponsor: **SIGA Technologies** · enrollment: 12 (actual)

## Conditions studied

- Orthopoxviral Disease
- Smallpox
- Monkey Pox

## Interventions

- **DRUG:** ST-246 Days 1 - 3
- **DRUG:** ST-246 Days 11 - 13

## Key facts

- **NCT ID:** NCT00728689
- **Lead sponsor:** SIGA Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00728689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00728689, "Phase I Trial of an Investigational Small Pox Medication". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00728689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*